Fig. 6From: Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AITGraphical illustration of assays used for measuring the AIT-induced capacity of antibodies to prevent IgE-Bet v 1 binding. FAB (a) and inhibition mediator release assays with T0 serum of each patient (b) or indicator serum pool (c) used as reference for therapy-induced antibodies to inhibit IgE-allergen bindingBack to article page